
David Robson
David Robson has spent his career concentrating on medical device development, including roles in R&D, project management, and regulatory compliance. In addition to multiple stints in startups and larger-scale OEMs, Robson spent 17 years at Ximedica (now Veranex), a contract medical device and IVD instruments design and development firm. In 2019, he was instrumental in converting an eye surgeon’s concept for micro-interventional glaucoma surgery instruments (MIGS) into a feasible and documented design suitable for human use. He joined the resulting company, Iantrek Inc., as the founding COO and was the primary architect for establishing the facility as well as the quality management system and the development of the company’s portfolio of products. As a result of Robson’s 35+ years in the medical device industry, he has accumulated an uncommon set of experiences with respect to outsourcing services, both as a customer and provider. He has experienced the many benefits (and some of the pitfalls) of strategically balancing permanent employees and vertically integrated manufacturing with outsourced expertise and services such as contract manufacturing.
Thursday September 18, 2025
Face to Face: Industry Execs Address Medtech’s Most Pressing Issues
Where are the pain points for today’s medical device manufacturers? How are others addressing these problems? What are the best practices taking place around the industry? This session will offer a candid discussion among industry peers who represent various aspects of the industry. A multitude of discussion topics will be touched upon, including supply chain, labor, regulatory, cost controls, among others. Further, attendees are encouraged to pose their own questions to the group or ask about a topic that concerns them.
Moderated by Julie Schulte.